These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1399728)

  • 1. Radiotherapy for prostate cancer: should the seminal vesicles be considered target?
    Marks LB; Anscher MS
    Int J Radiat Oncol Biol Phys; 1992; 24(3):435-40. PubMed ID: 1399728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introducing a prognostic score for pretherapeutic assessment of seminal vesicle invasion in patients with clinically localized prostate cancer.
    Salomon L; Porcher R; Anastasiadis AG; Levrel O; Saint F; De la Taille A; Vordos D; Cicco A; Hoznek A; Chopin D; Abbou CC; Lagrange JL
    Radiother Oncol; 2003 Jun; 67(3):313-9. PubMed ID: 12865180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivariate analysis of factors predicting local relapse after radical prostatectomy--possible indications for postoperative radiotherapy.
    Anscher MS; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):941-7. PubMed ID: 1917623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer.
    Diaz A; Roach M; Marquez C; Coleman L; Pickett B; Wolfe JS; Carroll P; Narayan P
    Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):323-9. PubMed ID: 7523343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer.
    D'Amico AV; Whittington R; Malkowicz SB; Schnall M; Tomaszewski J; Schultz D; Kao G; VanArsdalen K; Wein A
    Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):293-302. PubMed ID: 7928457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
    Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose-volume histogram analysis of the seminal vesicles in men treated with conformal radiotherapy to 'prostate alone'.
    Parker C; Haycocks T; Bayley A; Alasti H; Warde P; Catton C
    Clin Oncol (R Coll Radiol); 2002 Aug; 14(4):298-302. PubMed ID: 12206642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
    Michalski JM; Winter K; Purdy JA; Perez CA; Ryu JK; Parliament MB; Valicenti RK; Roach M; Sandler HM; Markoe AM; Cox JD
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):735-42. PubMed ID: 14967428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma.
    Villers AA; McNeal JE; Redwine EA; Freiha FS; Stamey TA
    J Urol; 1990 Jun; 143(6):1183-7. PubMed ID: 2342179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer.
    Bostwick DG; Qian J; Bergstralh E; Dundore P; Dugan J; Myers RP; Oesterling JE
    J Urol; 1996 Apr; 155(4):1361-7. PubMed ID: 8632575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative prostate specific antigen and prostate volume are significant predictors of seminal vesicle invasion in patients with prostate cancer.
    Sfoungaristos S; Perimenis P
    Prague Med Rep; 2011; 112(4):263-71. PubMed ID: 22142521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis.
    Epstein JI; Carmichael M; Walsh PC
    J Urol; 1993 May; 149(5):1040-5. PubMed ID: 8483205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of seminal vesicle involvement due to prostate cancer in radical prostatectomy specimens.
    Algarra R; Barba J; Merino I; Tienza A; Tolosa E; Robles JE; Zudaire J
    Actas Urol Esp; 2015 Apr; 39(3):144-53. PubMed ID: 24996780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The route of seminal vesicle involvement in adenocarcinoma of prostate: lymphaticovascular or local extension?
    Chuang YC; Chen KK; Chang KM; Lin AT; Chang YH; Wu HH; Chang LS
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Feb; 59(2):95-8. PubMed ID: 9175298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate.
    Oesterling JE; Brendler CB; Epstein JI; Kimball AW; Walsh PC
    J Urol; 1987 Jul; 138(1):92-8. PubMed ID: 3599229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications for preoperative seminal vesicle biopsies in staging of clinically localized prostatic cancer.
    Guillonneau B; Debras B; Veillon B; Bougaran J; Chambon E; Vallancien G
    Eur Urol; 1997; 32(2):160-5. PubMed ID: 9286646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seminal vesicle intraepithelial involvement by prostate cancer: putative mechanism and clinicopathological significance.
    Miyai K; Kristiansen A; Egevad L; Pina-Oviedo S; Divatia MK; Shen SS; Miles BJ; Ayala AG; Park YW; Ro JY
    Hum Pathol; 2014 Sep; 45(9):1805-12. PubMed ID: 24993314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expected benefit of lymph node and seminal vesical dissection to decrease high-risk prostate cancer radiotherapy].
    Colliaux J; Kharchi L; Vincendeau S; Simon A; Perdrieux M; Le Prisé É; Bellisant É; Castelli J; de Crevoisier R
    Cancer Radiother; 2016 Jul; 20(5):347-56. PubMed ID: 27344535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence and histogenesis of seminal vesicle adenocarcinoma and lower incidence of prostate carcinomas in the Lobund-Wistar prostate cancer rat model using N-nitrosomethylurea and testosterone.
    Tamano S; Rehm S; Waalkes MP; Ward JM
    Vet Pathol; 1996 Sep; 33(5):557-67. PubMed ID: 8885183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.